SMH
BIVI icon

Sanders Morris Harris’s BioVie BIVI Stock Holding History

Sanders Morris Harris’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,000
Closed -$37K – 311
2025
Q2 		$37K Hold
4,000
– – 0.01% 160
2025
Q1 		$39.2K Hold
4,000
– – 0.01% 275
2024
Q4 		$85.2K Buy
+4,000
New +$96.4K 0.01% 274

Other funds holding BIVI

DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
PWM
Prosperity Wealth Management San Ramon, California $300M AUM 28.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Sanders Morris Harris's BIVI Position: Q3 2025 in Review

Sanders Morris Harris sold out of BioVie (BIVI) in Q3 2025, closing a stake of 4,000 shares — an estimated $37K sold.

Sanders Morris Harris first reported a position in BIVI in Q4 2024 and held it in 3 quarters. The position peaked at $85.2K in Q4 2024. 32 funds tracked by Wall St. Rank hold BIVI as of Q3 2025.

  • Sanders Morris Harris reported no remaining BioVie position as of Q3 2025 after selling out during the quarter.
  • Sanders Morris Harris sold 4,000 BioVie shares in Q3 2025, an estimated $37K.
  • Sanders Morris Harris first reported a position in BioVie in Q4 2024 and held it in 3 quarters.
  • Sanders Morris Harris's BioVie position peaked at $85.2K in Q4 2024.
  • 32 funds tracked by Wall St. Rank held BioVie as of Q3 2025.

Based on Sanders Morris Harris's 13F filing for Q3 2025, filed 7 Oct 2025.